| Complement: a key system for immune surveillance and homeostasis D Ricklin, G Hajishengallis, K Yang, JD Lambris Nature immunology 11 (9), 785-797, 2010 | 4079 | 2010 |
| Complement evasion by human pathogens JD Lambris, D Ricklin, BV Geisbrecht Nature Reviews Microbiology 6 (2), 132-142, 2008 | 928 | 2008 |
| Complement-targeted therapeutics D Ricklin, JD Lambris Nature biotechnology 25 (11), 1265-1275, 2007 | 662 | 2007 |
| Complement in immune and inflammatory disorders: pathophysiological mechanisms D Ricklin, JD Lambris The Journal of Immunology 190 (8), 3831-3838, 2013 | 576 | 2013 |
| Complement in disease: a defence system turning offensive D Ricklin, ES Reis, JD Lambris Nature Reviews Nephrology 12 (7), 383-401, 2016 | 560 | 2016 |
| Complement component C3–The “Swiss Army Knife” of innate immunity and host defense D Ricklin, ES Reis, DC Mastellos, P Gros, JD Lambris Immunological reviews 274 (1), 33-58, 2016 | 550 | 2016 |
| Interactions between coagulation and complement—their role in inflammation K Oikonomopoulou, D Ricklin, PA Ward, JD Lambris Seminars in immunopathology 34, 151-165, 2012 | 488 | 2012 |
| Novel mechanisms and functions of complement G Hajishengallis, ES Reis, DC Mastellos, D Ricklin, JD Lambris Nature immunology 18 (12), 1288-1298, 2017 | 458 | 2017 |
| Structure of complement fragment C3b–factor H and implications for host protection by complement regulators J Wu, YQ Wu, D Ricklin, BJC Janssen, JD Lambris, P Gros Nature immunology 10 (7), 728-733, 2009 | 401 | 2009 |
| Complement in cancer: untangling an intricate relationship ES Reis, DC Mastellos, D Ricklin, A Mantovani, JD Lambris Nature Reviews Immunology 18 (1), 5-18, 2018 | 385 | 2018 |
| The renaissance of complement therapeutics D Ricklin, DC Mastellos, ES Reis, JD Lambris Nature Reviews Nephrology 14 (1), 26-47, 2018 | 380 | 2018 |
| Clinical promise of next-generation complement therapeutics DC Mastellos, D Ricklin, JD Lambris Nature reviews Drug discovery 18 (9), 707-729, 2019 | 312 | 2019 |
| Structures of C3b in complex with factors B and D give insight into complement convertase formation F Forneris, D Ricklin, J Wu, A Tzekou, RS Wallace, JD Lambris, P Gros Science 330 (6012), 1816-1820, 2010 | 286 | 2010 |
| Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor SHM Rooijakkers, J Wu, M Ruyken, R Van Domselaar, KL Planken, ... Nature immunology 10 (7), 721, 2009 | 272 | 2009 |
| Complement in immune and inflammatory disorders: therapeutic interventions D Ricklin, JD Lambris The Journal of Immunology 190 (8), 3839-3847, 2013 | 269 | 2013 |
| Oligohis‐tags: mechanisms of binding to Ni2+‐NTA surfaces S Knecht, D Ricklin, AN Eberle, B Ernst Journal of Molecular Recognition 22 (4), 270-279, 2009 | 267 | 2009 |
| Compstatin: a C3‐targeted complement inhibitor reaching its prime for bedside intervention DC Mastellos, D Yancopoulou, P Kokkinos, M Huber‐Lang, ... European journal of clinical investigation 45 (4), 423-440, 2015 | 234 | 2015 |
| Compstatin: a complement inhibitor on its way to clinical application D Ricklin, JD Lambris Current Topics in Complement II, 262-281, 2008 | 225 | 2008 |
| Innate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies KN Ekdahl, JD Lambris, H Elwing, D Ricklin, PH Nilsson, Y Teramura, ... Advanced drug delivery reviews 63 (12), 1042-1050, 2011 | 222 | 2011 |
| A structural basis for complement inhibition by Staphylococcus aureus M Hammel, G Sfyroera, D Ricklin, P Magotti, JD Lambris, BV Geisbrecht Nature immunology 8 (4), 430-437, 2007 | 213 | 2007 |
